The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, November 05, 2020
Novartis and Molecular Partners announced an option and license agreement to develop, manufacture and commercialize DARPin program.
read more
Thursday, November 05, 2020
Qualigen announced written feedback to its Type B Pre-IND meeting request from the FDA that is in general agreement with the Company's planned ...
read more
Thursday, November 05, 2020
Orasis announced the initiation of Phase 3 clinical studies in the U.S., evaluating its novel eye drop candidate designed to improve near vision for ...
read more
Tuesday, November 03, 2020
Oncolytics Biotech announced a new multi-indication gastrointestinal cancer study to be managed by AIO.
read more
Tuesday, November 03, 2020
Syntrix Pharmaceuticals has completed initial SX-682 dosing in Phase 1/2 trials in myelodysplastic syndromes (MDS) and metastatic melanoma.
read more
Monday, November 02, 2020
Agenus announced the dosing of the first COVID-19 patient with agenT-797, an allogeneic cell therapy, through its subsidiary, AgenTus Therapeutics.
read more
Monday, November 02, 2020
RevImmune announced its "ILIAD-7" international randomized controlled Phase 2 trial in patients critically ill with COVID-19, is now enrolling ...
read more
Seelos has been issued U.S. patent number 10815271 from the USPTO covering the composition of matter for SLS-007.
read more
The FDA has approved the NGS-based FoundationOne CDx test as a companion diagnostic to identify fusions in NTRK genes, NTRK1, NTRK2, and NTRK3, in DNA...
read more
Vanda announced the FDA has approved the IND application to evaluate Cystic Fibrosis Transmembrane Conductance Regulator activator VSJ-110 for ...
read more
Thursday, October 29, 2020
NBE-Therapeutics has commenced first-in-human studies of its lead program NBE-002 targeting ROR1, for triple negative breast cancer and other solid ...
read more
Thursday, October 29, 2020
Aeglea BioTherapeutics announced the FDA has granted Orphan Drug Designation to ACN00177 for the treatment of Homocystinuria.
read more
Wednesday, October 28, 2020
Bayer AG and Asklepios BioPharmaceutical (AskBio) announced an agreement under which Bayer will acquire AskBio.
read more
Wednesday, October 28, 2020
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled ...
read more
Wednesday, October 28, 2020
Vanessa Research (VR) has been granted positive orphan drug opinion by the EMA for their drug Shylicine.
read more